News Headlines Article

Hospitals, pharma could bear brunt of deficit-cutting measures, Moody’s says
Modern Healthcare

Hospitals and pharmaceutical companies will likely be hit hardest by proposals from the deficit-reduction supercommittee, Moody’s Investors Service said.

Proposals could include reduced federal funding to offset unpaid Medicare co-insurance or deductibles and medical education costs, Moody’s said in a quarterly report. Not-for-profit hospitals would be more vulnerable than for-profits to such reductions, the report said.